ClinicalTrials.gg
RecruitingNCT07233798Updated Mar 11, 2026

Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis

An observational study in Lumbar Spinal Stenosis, Numerical Rating Scale and Disability Physical, sponsored by Marmara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-03-11.

Sponsored by Marmara University · Observational

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Lumbar spinal stenosis is defined as the narrowing of the spinal canal resulting from degenerative changes in the spinal joints, intervertebral discs, and the ligamentum flavum.

Pressure fluctuations within the cerebral and spinal vascular systems lead to the formation of pulsations. The periodic occurrence of these pulsations in the dura mater is referred to as spinal dural pulsation.The vibratory movements of the dura mater have been interpreted as an indicator that the spinal cord is freely mobile within the subarachnoid space and not subjected to any external compression.This study aims to investigate whether the presence of dural pulsation is associated with clinical and radiological parameters in patients diagnosed with lumbar spinal stenosis

Read the detailed description

Lomber spinal stenosis is defined as a narrowing of the spinal canal resulting from degenerative changes in the spinal joints, intervertebral discs, and the ligamentum flavum. The reduction in the space surrounding the neurovascular structures may lead to significant clinical symptoms such as neurogenic claudication, radiating pain in the lower extremities, low back pain, and urinary or fecal incontinence. Symptoms often improve when patients sit down or lean forward. However, if the pain induced by standing or walking postures becomes severe, it may impair the ability to perform daily and independent activities.

Magnetic Resonance Imaging is the primary imaging modality for the diagnosis of LSS. It provides high sensitivity and specificity in identifying anatomical abnormalities such as disc herniation, facet joint degeneration, and hypertrophy of the ligamentum flavum. However, as MRI findings may be influenced by factors such as patient positioning and imaging protocols, the interpretation of MRI should always be correlated with clinical findings in the diagnosis of LSS.

Periodic oscillations within the central nervous system occur due to pressure changes in the cerebral and spinal vascular systems. The rhythmic occurrence of these oscillations at the level of the dura mater is referred to as spinal dural pulsation. In previous studies, the vibratory movements of the spinal cord, dura mater, and cerebrospinal fluid (CSF) have been observed intraoperatively and evaluated in detail using MRI. Surgeons have interpreted these rhythmic movements of the dura mater as an indication that the spinal cord is freely suspended within the subarachnoid space and not subjected to external compression. This has been considered in earlier studies as a finding correlated with the presence of spinal dural pulsation.In this study, patients will be placed in the prone position, and the presence of dural pulsation will be evaluated using ultrasound.

The aim of this study is to evaluate the relationship between the presence of spinal dural pulsation and the clinical and radiological findings in patients diagnosed with lumbar spinal stenosis.

This study has been approved by the Marmara University Faculty of Medicine Non-Pharmaceutical and Non-Medical Device Clinical Trials Ethics Committee with the ethics approval number 09.2025.25-0459.

02

Conditions studied

  • Lumbar Spinal Stenosis
  • Numerical Rating Scale
  • Disability Physical
  • Magnetic Resonance
  • Claudication

Keywords

  • Dural Pulsation
  • oswestry disability index
03

In context

Spinal Stenosis

458 studies on the registry are indexed under Spinal Stenosis; 105 are open to participants now.

This study's planned enrollment of 100 is below the median of 120 across 154 observational studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

Marmara University is the lead sponsor of 599 studies on the registry; 138 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients aged between 18 and 85 years diagnosed with lumbar spinal stenosis based on physical examination, clinical evaluation, and lumbar magnetic resonance imaging.

Eligibility criteria

Inclusion criteria

  • Aged between 18 and 85 years
  • Patients experiencing low back and/or leg pain attributable to lumbar spinal stenosis
  • Presence of lumbar spinal stenosis at least at one level consistent with clinical symptoms on lumbar MRI
  • Willingness to participate in the study Exclusion criteria
  • (BMI) ≥ 35 kg/m²
  • Patients with radiculopathy due to lumbar disc herniation
  • Patients with axial low back pain caused by facet syndrome, sacroiliac dysfunction, or discogenic pain
  • History of lumbar spine surgery
  • Individuals with mental retardation
  • Patients with major psychiatric comorbidities
  • Patients with congenital spinal anomalies
  • Inflammatory rheumatic diseases characterized by osteophyte formation and ligament calcification, such as ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis (DISH)
  • Pregnancy
  • Patients with heart failure
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Positive for dural pulsation
  • Negative for dural pulsation
06

What researchers measure

Primary outcomes

  1. The Numeric Rating Scale (NRS)

    The Numeric Rating Scale (NRS) is a unidimensional, self-reported measure of pain intensity that is widely used in both clinical practice and research, including studies involving patients with chronic pain. On this scale, patients rate their current level of pain on an 11-point numeric range from 0 to 10, where 0 represents "no pain" and 10 represents "the worst pain imaginable." Higher scores indicate greater pain intensity.

    Time frame: At the time of data collection

  2. Oswestry Disability Index

    The Oswestry Disability Index (ODI) is a widely used and validated questionnaire designed to assess the degree of disability and functional impairment in patients with low back pain. It evaluates the impact of pain on various aspects of daily living and physical function through ten sections, each scored from 0 to 5, with higher scores indicating greater disability. The total score is converted into a percentage by dividing the obtained score by the maximum possible score and multiplying by 100, yielding a final score ranging from 0% (no disability) to 100% (maximum disability).

    Time frame: At the time of data collection

  3. SHORT FORM-12

    The Short Form-12 (SF-12) is a health-related quality of life assessment tool that summarizes an individual's physical and mental health status through 12 items. It is a shortened version of the SF-36 questionnaire and measures eight health domains: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. The SF-12 produces two composite scores - the Physical Component Summary (PCS) and the Mental Component Summary (MCS) - which are standardized to a mean of 50 and a standard deviation of 10 in the general population. Higher scores indicate better health status and quality of life.

    Time frame: At the time of data collection

  4. Walking Distance Capacity

    Time frame: At the time of data collection

Secondary outcomes

  1. Dural anteroposterior diameter measured by MRI at the stenotic level

    Time frame: At the time of data collection

  2. Dural cross-sectional area measured by MRI at the stenotic level

    Time frame: At the time of data collection

  3. Schizas classification of the stenotic level on MRI

    The Schizas classification is a qualitative grading system used to assess the severity of lumbar spinal canal stenosis on axial T2-weighted magnetic resonance imaging (MRI). It is based on the morphology of the dural sac and the distribution of cerebrospinal fluid (CSF) and nerve rootlets within the canal. The classification includes five grades (A-E): Grade A: Clearly visible CSF surrounding all cauda equina rootlets (no stenosis). Grade B: Some aggregation of rootlets, but CSF still visible (mild stenosis). Grade C: Rootlets form a dense bundle with minimal CSF signal (moderate stenosis). Grade D: No visible CSF, rootlets fill the dural sac (severe stenosis). Grade E: Dural sac completely obliterated or replaced by epidural fat or fibrosis (extreme stenosis). Higher grades correspond to more severe central canal stenosis.

    Time frame: At the time of data collection

07

Study locations

1 of 1 sites recruiting
  • Marmara University Faculty of Medicine, Pendik Training and Research Hospital, Algology Department
    Pendik, Istanbul 34890, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07233798
Lead sponsor
Marmara University
Responsible party
Sponsor
First posted
Nov 18, 2025
Start date
Dec 7, 2025
Primary completion
Dec 20, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Mar 11, 2026

Study contacts

Fatma B Akdağ, Research Assistant
Contact
fatma.betul820@gmail.com
+90 537 452 96 60
Savaş Şencan, Associate Professor
Contact
savas-44@hotmail.com
+90 537 066 57 13
Fatma B Akdağ, Research Assistant
principal investigator · Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation
Osman H Gündüz, Professor
study director · Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine
Serdar Kokar, Associate Professor
study director · Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine
Savaş Şencan, Associate Professor
study director · Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion